期刊文献+

肿瘤坏死因子α增强肾小球系膜细胞胞内钙释放参与肝肾综合征发病机制 被引量:4

Enhanced calcium release induced by tumor necrosis factor alpha in glomerular mesangial cells par- ticipated in hepatorenal syndrome
原文传递
导出
摘要 目的研究肿瘤坏死因子α(TNF-α)对肾小球系膜细胞(GMCs)胞内钙离子浓度([Ca2+]i)及细胞收缩的影响,证明TNF-α通过1,4,5-三磷酸肌醇受体(IP3Rs)增强GMCs对缩血管物质的易感性是肝肾综合征的重要机制。方法应用大鼠GMCs株,测量时均选无钙缓冲液及内皮素(ET)刺激。分正常对照ET刺激组(0h组)、TNF-α处理4hET刺激组(4h组)、TNF-α处理24hET刺激组(24h组);另设上述3组于ET前10min加入IP3Rs阻断剂2-氨基乙氧基联苯硼酸盐(2-APB)。应用Fluo-3/AM标记及激光共聚焦显微镜,观察TNF-α预处理后GMCs对ET刺激后[ca2+]i的变化及2-APB阻断后的变化。同时测量各组GMCs收缩前后表面积的变化以明确收缩幅度。结果ET刺激可使GMCs在短时间内[Ca22+]i迅速、显著增加,TNF-α4h、24h组[Ca2+]i上升幅度尤为明显[4h:(648.08±267.11)nmol/L;24h:(879.30±260.29)nmol/L;0h:(619.93±258.94)nmol/L,F:5.486,4hvs0h:P〈0.05;24hvs0h:P〈0.05;24hvs4h:P〉0.05]。2-APB阻断后3组细胞对ET刺激均失去反应,[Ca2+]i无上升。ET刺激可使各组细胞面积缩小;TNF-α 4h、24h组上述效应更加明显[4h:(2198±340)μm2;24h:(2260±553)μm2;0h:(2436±474)μm2,F=4.001,4hvs0h:P〈0.05;24hvs0h:P〈0.05;24hvs4h:P〉0.05)。结论TNF-α可增加ET刺激引起的[Ca2+]i上升进而引起细胞收缩,并证明是通过IP3Rs通路产生效应的,这可能是肝肾综合征时肾脏对缩血管物质产生高敏性进而引起。肾小球滤过率下降的重要机制。 Objective To investigate the effect of tumor necrosis factor-α (TNF-α) on intracellular calcium concentration ( [ Ca2 +] i ) and the contraction of glomerular mesangial cells ( GMCs), and prove that hypercontractility of GMCs induced by TNF-α in hepatorenal syndrome(HRS) was connected with inositol 1,4,5-trisphophate receptors (IP3Rs). Methods GMCs were divided into TNF-α-treated 0 h, 4 h, and 24 h groups. Another 3 groups were blocked by 2-APB. The effect of TNF-αon [ Ca2 + ] i was identified and observed whether it could be blocked by 2-APB. Contraction of GMCs was determined by accessing the surface area of cells before and after contraction. Results TNF-α significantly increased ET-induced calcium release, in that we found higher [ Ca2 + ] i after stimulated by ET in TNF-α -treated 4 h group and 24 h group[ 4 h: (648.08 ± 267.11 )nmol/L; 24 h: (879. 30 ±260. 29) nmol/L; 0 h: (619. 93 ± 258. 94) nmol/L,F =5.486,4hvs0h:P 〈0.05;24hvs0h:P 〈0.05;24hvs4h:P 〉0.05]. This phenomenon can be totally blocked by 2-APB in all groups. The change in planar surface area in response to ET was slightly in control cells but significantly enhanced in TNF-α -treated cells [ 4 h:(2198 ± 340)μm2; 24 h: (2260 ~553) μm2 ; 0 h: (2436 ±474) μm2, F =4. 001,4 h vs 0 h: P 〈0. 05 ; 24 h vs 0 h: P 〈0. 05 ;24 h vs 4 h : P 〉 0. 05 ]. Conclusion TNF-α can enhance ET-induced sarcoptasmic reticulum Ca2 + re-lease and increase the contractile responses of GMCs to ET, which is associated with IP3Rs. TNF-α is re-sponsible for hyperconstractility of glomeruli in HRS.
出处 《中国医师杂志》 CAS 2013年第1期11-14,共4页 Journal of Chinese Physician
基金 国家自然科学基金(N030270607)
关键词 肿瘤坏死因子Α 代谢 肾小球膜 细胞学 肝肾综合征 Tumor necrosis factor-alpha Calcium/metabolism Glomerular mesangium/cytology Hepatorenal syndrome
  • 相关文献

参考文献11

二级参考文献38

  • 1吕飒,宋红丽,王静艳,刘沛.急性肝坏死小鼠血脑屏障通透性的改变[J].世界华人消化杂志,2004,12(6):1346-1348. 被引量:10
  • 2姚宇玫,胡申江,黄元伟,杨春虎,孙坚,朱朝晖,吴涛.肿瘤坏死因子α对心肌细胞内受磷蛋白表达和细胞内钙的调节作用[J].中国医学科学院学报,2005,27(6):767-771. 被引量:4
  • 3Arroyo V, Gin s P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996,23( 1 ) : 164-176.
  • 4Duvoux C, Zanditenas D, H 6 zode C, et al. Effects of noradrenalin and albumin in patients with type | hepatorenal syndrome:a pilot study. Hepatology, 2002,36(2 ) : 374-378.
  • 5Ruiz-del-Arbol L,Monescillo A,Amcena C,et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology, 2005,42( 2 ) : 439-447.
  • 6Ruiz-del-Arbol L,Urman J,Fernandez J,et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 2008,38 ( 5 ) : 1210- 1218.
  • 7Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective muhicenter study. Gastroenterology, 2002,122 (4) : 923-930.
  • 8Bardi A, Sapunar J, Oksenberg D, et al. Intrarenal arterial doppler uhrasonography in cirrhotic patients with aseites, with and without hepatorenal syndrome. Rev Med C hil, 2002,130(2): 173-180.
  • 9Muto Y, Nouri-Aria KT, Meager A, et al. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet , 1988, 2:72-74.
  • 10Shapira L, Soskolne WA, Houri Y, et al. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun , 1996,64:825-828.

共引文献29

同被引文献56

  • 1王静艳,刘洪艳,刘沛.肝硬化大鼠肾小球血管袢和肾小球前小动脉Ⅰ型1,4,5-三磷酸肌醇受体的表达[J].中华肝脏病杂志,2004,12(10):609-611. 被引量:3
  • 2Ying Wen Wei Cui Pei Liu.TypeⅠinositol 1, 4, 5-triphosphate receptors increase in kidney of mice with fulminant hepatic failure[J].World Journal of Gastroenterology,2007,13(16):2344-2348. 被引量:7
  • 3闻颖,崔巍,刘沛.暴发性肝衰竭时肾脏Ⅰ型1,4,5-三磷酸肌醇受体表达增加[J].中华肝脏病杂志,2007,15(6):403-407. 被引量:5
  • 4Tahir F, Riaz H, Hehman A, et al. Potential role of TNF alphablockers in delaying the progression of hepato-renal syndrome.Med Hypotheses,2012,78(2) :225-226. doi: 10. 1016/j. mehy.2011.10.030.
  • 5Nowak G, Bakajsova D. Protein kinase C-a activation promotesrecovery of mitochondrial function and cell survivalfollowing oxi-dant injury in renal cells. Am J Physiol Renal Physiol,2012,303(4):F515-F526. doi: 10. 1152/ajprenal. 00072. 2012.
  • 6Coward J, Ambrosini G, Musi E, et al. Safingol (L-threo-sphin-ganine) induces autophagy in solid tumor cells through inhibitionof PKCand the PI3-kinase pathway. Autophagy,2009,5(2) : 184-193.
  • 7Prakash J,Mahapatra AK,Ghosh B,et al. Clinical spectrum of re-nal disorders in patients with cirrhosis of liver. Ren Fail,2011 ,33(1):4046. doi: 10. 3109/0886022X. 2010.541582.
  • 8Kayali Z, Herring J, Baron P, et al. Increased plasma nitric ox-ide, L-arginine, and arginase-1 in cirrhotic patients with progres-siverenal dysfunction. J Gastroenterol Hepatol,2009, 24 ( 6 ):1030-1037. doi: 10.1111/j. 1440-1746.2008.05757. x.
  • 9Wong F. Recent advances in our understanding of hepatorenalsyndrome. Nat Rev Gastroenterol Hepatol,2012,9(7) :382-391.doi: 10. 1038/nrgastro. 2012.96.
  • 10Odeh M. Response to relationship between circulating levels oftumour necrosis factor-alpha and Child-Pugh scores in liver cir-rhosis. Int J Clin Pract,2007,61 (3) :520. 520.

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部